Loglime 2mg/500mg/15mg Tablet ER
Marketer
Sanify Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Loglime 2mg/500mg/15mg Tablet ER
DiaBeta-XR 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and duration for DiaBeta-XR 2mg/500mg/15mg ER Tablets; take with food to prevent gastric discomfort. For missed doses, take promptly unless nearing the next scheduled dose; avoid doubling up. Overdosing can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; monitor blood sugar frequently. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions to your doctor before starting treatment. Pregnant or lactating individuals should seek medical advice. Kidney function tests are typically assessed before treatment commences. Limit alcohol consumption to mitigate potential side effects.
Uses of Loglime 2mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Loglime 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Loglime 2mg/500mg/15mg Extended-Release tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.
Common Side effects of Loglime 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Loglime 2mg/500mg/15mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Loglime 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume with a meal.
How Loglime 2mg/500mg/15mg Tablet ER works:
Loglime ER tablets (2mg/500mg/15mg) combine three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts via a triple mechanism: reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Loglime 2mg/500mg/15mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Loglime tablets (2mg/500mg/15mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Loglime tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Loglime 2mg/500mg/15mg Extended-Release tablets, as dose modification may be necessary. Consult your physician for guidance. Loglime 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Loglime 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Loglime 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Loglime 2mg/500mg/15mg Tablet ER :
Should you forget to take a Loglime 2mg/500mg/15mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Loglime 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently